Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cutaneous Waldenström's macroglobulinemia].

F Mantoux1, J Castanet, C Perrin

  • 1Service de Dermatologie, Hôpital Archet 2, Nice. mantoux.f@chu-nice.fr

Annales De Dermatologie Et De Venereologie
|April 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regorafenib as maintenance therapy after first-line doxorubicin-based chemotherapy in advanced non-adipocytic soft tissue sarcomas patients: a double-blind randomised trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project.

ESMO open·2024
Same author

Improved nationwide survival of sarcoma patients with a network of reference centers.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.

European journal of cancer (Oxford, England : 1990)·2023
Same author

Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years.

European journal of cancer (Oxford, England : 1990)·2023
Same author

Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study.

ESMO open·2023

Waldenström's macroglobulinemia can manifest as skin lesions. This case study shows successful treatment of cutaneous Waldenström's macroglobulinemia with chlorambucil chemotherapy, highlighting its potential efficacy.

Area of Science:

  • Hematology
  • Dermatology
  • Oncology

Background:

  • Waldenström's macroglobulinemia (WM) is a rare lymphoproliferative disorder.
  • Cutaneous involvement in WM is uncommon, presenting diagnostic and therapeutic challenges.

Observation:

  • A 76-year-old woman presented with chronic, red, nodular skin lesions on her face.
  • Biopsy revealed a lymphocytic dermal infiltrate with a monoclonal B lymphoid population (IgM-kappa).
  • Diagnosis confirmed as WM with cutaneous localization based on high IgM levels and bone marrow findings.

Findings:

  • Initial radiotherapy was ineffective.
  • Chlorambucil chemotherapy led to rapid resolution of skin lesions.
  • Lesions relapsed but responded to a lower dose of chlorambucil after initial neutropenia.

Related Experiment Videos

Implications:

  • This case suggests chlorambucil can be effective for cutaneous WM, even after initial treatment withdrawal.
  • Rare cutaneous manifestations of WM require tailored therapeutic approaches.
  • Further research into optimal chemotherapy regimens for cutaneous WM is warranted.